Evidence and Controversies in the treatment of metastatic NSCLC

Posted On 2020-12-29 14:13:34


The series on “Evidence and Controversies in the treatment of metastatic NSCLC” is edited by Dr. Grace K. Dy, MD, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. This series has included a collection of debate-style brief editorials, featuring back-to-back pro/con position from different clinical experts in the field.


Disclosure:
The series “Evidence and Controversies in the treatment of metastatic NSCLC” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Grace K. Dy served as the unpaid Guest Editor for the series.